Last edition
News about "Eris Lifesciences "
Eris Lifesciences Launches Weekly Semaglutide Shot at INR 220 in India
Eris Lifesciences has launched a weekly Semaglutide injection starting at INR 220 per dose and plans to introduce a pen-device version in April, priced between INR 4,000 and INR 4,500 per month to enhance patient convenience and adoption.
Eris Lifesciences | 21/03/2026 | By News Bureau | 340
Eris Lifesciences to Increase Its Stake in Swiss Parenterals
Eris Lifesciences has announced plans to consolidate its stake in Swiss Parenterals, while bringing Naishadh Shah on board as a top-10 shareholder and part of the management, strengthening its leadership and long-term strategic vision.
Eris Lifesciences | 27/11/2025 | By Dineshwori | 115
Eris Lifesciences Secures ANVISA Approval for Sterile Injectable Facility in Ahmedabad
Eris Lifesciences has received Anvisa approval for one of its sterile injectable manufacturing facilities in Ahmedabad, enabling entry into the Brazilian market.
Eris Lifesciences | 26/08/2025 | By Mrinmoy Dey | 305
Eris Lifesciences Secures ANVISA Approval for its Manufacturing Unit in Ahmedabad
Eris Lifesciences has received ANVISA approval for a manufacturing unit at its Ahmedabad campus, paving the way for entry into Brazil, South America’s largest pharmaceutical market.
Eris Lifesciences | 25/08/2025 | By Mrinmoy Dey | 409
Eris Lifesciences Announces Acquisition of Biocon Biologics
Eris Lifesciences Ltd. has recently acquired Biocon Biologics’ Branded Formulations business in India in a deal worth INR 1,242 crore.
Eris Lifesciences | 19/03/2024 | By Manvi | 612
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy